. | Baseline . | 6-Week Visit . | 12-Week Visit . |
---|---|---|---|
Person with dementia | |||
Informed consent or assent | X | ||
Medical history | X | ||
MoCA | |||
Possible score range 0–30 | X | ||
Higher score = better cognition | |||
QOL-AD: Patient Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
Caregiver | |||
Informed consent | X | ||
QOL-AD: Informant Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
NPI | |||
Possible score range 0–168 | X | X | X |
Higher score = worse symptoms | |||
DAD | |||
Possible score range 0–100% | X | X | X |
Higher score = better function | |||
ZBI | |||
Possible score range 0–88 | X | X | X |
Higher score = worse burden | |||
RSCSE | |||
Possible score range 0-1500 | X | X | X |
Higher score = better self-efficacy |
. | Baseline . | 6-Week Visit . | 12-Week Visit . |
---|---|---|---|
Person with dementia | |||
Informed consent or assent | X | ||
Medical history | X | ||
MoCA | |||
Possible score range 0–30 | X | ||
Higher score = better cognition | |||
QOL-AD: Patient Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
Caregiver | |||
Informed consent | X | ||
QOL-AD: Informant Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
NPI | |||
Possible score range 0–168 | X | X | X |
Higher score = worse symptoms | |||
DAD | |||
Possible score range 0–100% | X | X | X |
Higher score = better function | |||
ZBI | |||
Possible score range 0–88 | X | X | X |
Higher score = worse burden | |||
RSCSE | |||
Possible score range 0-1500 | X | X | X |
Higher score = better self-efficacy |
Note. X = administered; DAD = Disability Assessment for Dementia; MoCA = Montreal Cognitive Assessment; NPI = Neuropsychiatric Inventory; QOL-AD = Quality of Life in Alzheimer’s Disease; RSCSE = Revised Scale for Caregiver Self-Efficacy; ZBI = Zarit Burden Inventory.
. | Baseline . | 6-Week Visit . | 12-Week Visit . |
---|---|---|---|
Person with dementia | |||
Informed consent or assent | X | ||
Medical history | X | ||
MoCA | |||
Possible score range 0–30 | X | ||
Higher score = better cognition | |||
QOL-AD: Patient Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
Caregiver | |||
Informed consent | X | ||
QOL-AD: Informant Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
NPI | |||
Possible score range 0–168 | X | X | X |
Higher score = worse symptoms | |||
DAD | |||
Possible score range 0–100% | X | X | X |
Higher score = better function | |||
ZBI | |||
Possible score range 0–88 | X | X | X |
Higher score = worse burden | |||
RSCSE | |||
Possible score range 0-1500 | X | X | X |
Higher score = better self-efficacy |
. | Baseline . | 6-Week Visit . | 12-Week Visit . |
---|---|---|---|
Person with dementia | |||
Informed consent or assent | X | ||
Medical history | X | ||
MoCA | |||
Possible score range 0–30 | X | ||
Higher score = better cognition | |||
QOL-AD: Patient Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
Caregiver | |||
Informed consent | X | ||
QOL-AD: Informant Version | |||
Possible score range 13–52 | X | X | X |
Higher score = better quality of life | |||
NPI | |||
Possible score range 0–168 | X | X | X |
Higher score = worse symptoms | |||
DAD | |||
Possible score range 0–100% | X | X | X |
Higher score = better function | |||
ZBI | |||
Possible score range 0–88 | X | X | X |
Higher score = worse burden | |||
RSCSE | |||
Possible score range 0-1500 | X | X | X |
Higher score = better self-efficacy |
Note. X = administered; DAD = Disability Assessment for Dementia; MoCA = Montreal Cognitive Assessment; NPI = Neuropsychiatric Inventory; QOL-AD = Quality of Life in Alzheimer’s Disease; RSCSE = Revised Scale for Caregiver Self-Efficacy; ZBI = Zarit Burden Inventory.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.